Effect of including (versus excluding) fates worse than death on utility measurement

International Journal of Technology Assessment in Health Care

Volumn 19, Issue 2, 2003, Pages 347-361

  Franic, Duska M ^a   Pathak, Dev S ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Death; Patient preference; QALY; Visual analogue scale

Indexed keywords

ESTIMATION; PATIENT TREATMENT; TUMORS;

STANDARD GAMBLE (SG) METHOD;

HEALTH CARE;

ADULT; ARTICLE; BODY WEIGHT; BREAST CARCINOMA; CANCER MORTALITY; CANCER RECURRENCE; CANCER THERAPY; CONTROLLED STUDY; DEATH; FEMALE; HEALTH CARE FACILITY; HEALTH STATUS; HUMAN; PREVALENCE; SCALE UP; SCORING SYSTEM; STANDARDIZATION; STATISTICAL SIGNIFICANCE; STUDENT T TEST; VISUAL ANALOG SCALE;

EID: 0038016426     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S026646230300031X     Document Type: Article

References (42)

1. Arnesen T, Nord E. The value of DALY life: Problems with ethics and validity of disability adjusted life years. BMJ. 1999;319:1423-1425.
2. Badia X, Monserrat R, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade off values for EQ-5D health states. Med Decis Making. 2001;21:7-16.
3. Bala MV, Zarkin GA. Are QALYs an appropriate measure for valuing morbidity in acute diseases? Health Econ Lett. 1999;3:10-13.
4. Birch S, Gafni A. Cost effectiveness and/utility analysis. Do current decision rules lead us to where we want to be? J Health Econ. 1992;11:279-296.
5. Brazier J, Deverill M. A checklist for judging preference based measures of health related quality of life: Learning from psychometrics. Health Econ. 1999;8:41-51.
6. Ciampi A, Silberfield M, Till JE. Measurement of individual preferences: The importance of situation specific variables. Med Decis Making. 1982;2:483-95.
7. Clarke AE, Goldstein MK, Garber AM, Lenert LA. The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Qual Life Res. 1997;6:169-184.
8. Cohen J. Statistical Power Analysis For The Behavioral Sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates Publishers; 1988.
9. Ditto PH, Druley JA, Moore KA, Danks JH, Smucker WD. Fates worse than death: The role of valued life activities in health state evaluations. Health Pschol. 1996;15:332-343.
10. Franic DM. Relating Quality Adjusted Life Years To Contingent Valuation: Acute Versus Chronic Conditions [dissertation]. Columbus (OH): The Ohio State University; 2000.
11. Franic DM, Pathak DS, Gafni A. Are health states "timeless": A case study of an acute condition-post chemotherapy nausea and vomiting. J Eval Clin Pract. 2003;69-82.
12. Froberg DG, Kane RL. Methodology for measuring health-state preferences-1: Measurement strategies J Clin Epidemiol. 1989;42:345-354.
13. Froberg DG, Kane RL. Methodology for measuring health-state preferences-2: Scaling methods. J Clin Epidemiol. 1989;42:459-471.
14. Froberg DG, Kane RL. Methodology for measuring health-state preferences-3: Population and context effects. J Clin Epidemiol. 1989;42:585-592.
15. Froberg DG, Kane RL. Methodology for measuring health-state preferences-4: Progress and research agenda. J Clin Epidemiol. 1989;42:675-685.
16. Furlong W, Feeney D, Torrance GW, et al. Guide to design and development of health state utility instrumentation. Center Health Economics Policy Analysis Working Paper Series. Paper No. 90-9. McMaster University: Hamilton, Ontario; 1990.
17. Gafni A. Willingness to pay in the context of an economic evaluation of healthcare programs: Theory and practice. Am J Manag Care. 1997;3(suppl):S21-S32.
18. Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analysis. Med Care. 1998;36:778-792.
19. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press; 1996.
20. Gold MR, Stevenson D, Fryback DG. HALYs, QALYs and DALYs, oh my: Similarities, differences in summary measures of population health. Annu Rev Public Health. 2002;23:115-134.
21. Haigh THB, Scott DA, Wickett LI. The rational zero point for an illness index with ratio properties. Med Care. 1986;24:113-124.
22. Imbasciati E, Surian M. When dialysis becomes worse than death. Nephrol Dial Transplant. 1996;11:1484-1485. Letter.
23. Lenert LA, Cher DJ, Goldstein MK, et al. The effect of search procedures on utility elicitations. Med Decis Making. 1998;18:76-83.
24. Lenert L, Morss S, Goldstein M, et al. Measurement of the validity of utility elicitations. Med Care. 1997;35:915-920.
25. Llewellyn-Thomas H, Sutherland HJ, Tibishirani R, et al. The measurement of patients' values in medicine. Med Decis Making. 1982;2:449-462.
26. Llewellyn-Thomas HA, Sutherland HJ, Tibshirani R, et al. Describing health states methodologic issues in obtaining values for health states. Med Care. 1984;22:543-552.
27. Macran S, Kind P. Death and the valuation of health related quality of life. Med Care. 2001;39:217-227.
28. Mitchell C. When living is a fate worse than death. Newsweek. 2000;136:12.
29. National Alliance of Breast Cancer Organizations (NABCO). Facts about breast cancer in the USA. Available at: http://www.nabco.org/resources/facts/usafacts.html. Accessed February 20, 2000.
30. Nord E. Methods for quality adjustment of life years. Soc Sci Med. 1992;34:559-569.
31. O'Brien BJ. Health state utility anchors: Being clear on what "1" means. Med Decis Making. 1997;17:352-353.
32. O'Hanlon M, Fox-Rushby J, Buxton MJ. A qualitative and quantitative comparison of the EuroQol and time-trade off techniques. Int J Health Sci. 1984;5:85-97.
33. Pathak DS. QALYs in health outcomes research: Representation of real preferences or another numerical abstraction. J Res Pharm Econ. 1995;6:3-27.
34. Patrick DL, Starks HE, Cain KC, et al. Measuring preferences for health states worse than death. Med Decis Making. 1994;14:9-18.
35. Pearlman RA, Cain KC, Patrick DL, et al. Insights pertaining to patient assessments of states worse than death. J Clin Ethics. 1993;4:33-41.
36. Post PN, Stigglebout AM, Wakker PP. The utility of health states after stroke a systematic review of the literature. Stroke. 2001;32:1425-1429.
37. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes: Comparison of assessment methods. Med Decis Making. 1984;4:315-329.
38. Sessa A. When dialysis becomes worse than death. Nephrol Dial Transplant. 1995;10:1128-30.
39. Spector PE. Research Designs. Sullivan JL, Niemi RG, eds. Beverly Hills, CA: Sage Publications; 1987.
40. Torrance GW. Social preferences for health states: An empirical evaluation of three measurement techniques? Socio-Econ Plan Sci. 1976;10:129-136.
41. Torrance GW. Health States Worse Than Death. In: von Eimeren W, Engelbrecht R, Flagle CD, eds. Third International Conference on System Science in Health Care, Berlin, Germany: Springler-Verlag; 1984:1085-1089.
42. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1-30.